There are 2867 resources available
1442P - Prevalence and factors associated with professional burnout in Polish oncologists: A nationwide survey by Young Oncologists Section of Polish Society of Clinical Oncology
Presenter: Pawel Sobczuk
Session: Poster session 04
1443P - Intimate partner violence in cancer patients: An SOS call
Presenter: Ines Lajnef
Session: Poster session 04
1444P - Cancer diagnosis communication: The perspective of oncologists, patients and caregivers
Presenter: Chiara Paratore
Session: Poster session 04
1445P - Family dynamics of pediatric oncology patients in a level III clinic in the city of Cali
Presenter: Valeria Santa Ovalles
Session: Poster session 04
1446P - Barriers and facilitators for genetic/epigenetic screening trials attendance in healthy populations at high-risk for cancer: A qualitative study
Presenter: Serena Oliveri
Session: Poster session 04
1530P - Durvalumab (D) + platinum-etoposide (EP) in first-line extensive-stage SCLC (ES SCLC): Effect of age and platinum agent on outcomes in CASPIAN
Presenter: Niels Reinmuth
Session: Poster session 04
1531P - Primary results from IMfirst, a phase IIIb open label safety study of atezolizumab (ATZ) + carboplatin (CB)/cisplatin (CP) + etoposide (ET) in an interventional real-world (RW) clinical setting of extensive-stage small cell lung cancer (ES-SCLC) in Spain
Presenter: Maria Rosario Garcia Campelo
Session: Poster session 04
1532P - Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Preliminary efficacy results
Presenter: Dolores Isla
Session: Poster session 04
1533P - Atezolizumab (ATZ) plus carboplatin (Cb) and etoposide (eto) in patients with untreated extensive-stage small cell lung cancer (ES-SCLC): Results from the interim analysis of MAURIS trial
Presenter: Emilio Bria
Session: Poster session 05
1534P - Phase II study of berzosertib + topotecan in patients with relapsed platinum (Pt)-resistant SCLC (DDRiver SCLC 250): Japanese safety run-in
Presenter: Tatsuya Yoshida
Session: Poster session 05